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Synthesis and analysis of the anticancer activity
of platinum(II) complexes incorporating
dipyridoquinoxaline variants†
Benjamin J. Pages,a,b Feng Li,a,b Paul Wormell,b Dale L. Ang,a,b Jack K. Clegg,c
Cameron J. Kepert,d Lawson K. Spare,a,b Supawich Danchaiwijita,b and
Janice R. Aldrich-Wright*a,b
Eight platinum(II) complexes with anticancer potential have been synthesised and characterised. These
complexes are of the type [Pt(IL)(AL)]
2+, where IL is either dipyrido[3,2-f:2’,3’-h]quinoxaline (dpq) or
2,3-dimethyl-dpq (23Me2dpq) and AL is one of the R,R or S,S isomers of either 1,2-diaminocyclohexane
(SS-dach or RR-dach) or 1,2-diaminocyclopentane (SS-dacp or RR-dacp). The CT-DNA binding of these
complexes and a series of other complexes were assessed using fluorescent intercalator displacement
assays, resulting in unexpected trends in DNA binding affinity. The cytotoxicity of the eight synthesised
compounds was determined in the L1210 cell line; the most cytotoxic of these were [Pt(dpq)(SS-dach)]Cl2
and [Pt(dpq)(RR-dach)]Cl2, with IC50 values of 0.19 and 0.80 μM, respectively. The X-ray crystal structure
of the complex [Pt(dpq)(SS-dach)](ClO4)2·1.75H2O is also reported.
Introduction
Chemotherapy is currently the most-utilised treatment for
cancer, one of the most globally prominent diseases.1 Among
currently used chemotherapeutics, platinum complexes are
held in high regard, with approximately 60% of treatment
schemes utilising cisplatin and its analogues.2 These com-
plexes are known to induce apoptosis in cancerous cells
through the formation of DNA adducts, resulting in the cross-
linking, bending, and unwinding of the helix.3 However, these
drugs are far from ideal chemotherapeutic agents as their
treatment often results in toxic side-effects, and these com-
pounds encounter intrinsic and acquired resistance from
many lines of cancerous cells.4,5 Recent attempts to overcome
these limitations have involved the development of non-classi-
cal platinum-based chemotherapeutics. These compounds
have great potential as chemotherapeutic agents as they are
able to both bypass traditional cell resistance mechanisms and
exert higher cytotoxicity than cisplatin and its analogues.6–9
To this end, our group has developed a large family of plati-
num(II) complexes (PCs), many of which are more biologically
active than cisplatin in many cell lines.10 The general structure
of these complexes is [Pt(IL)(AL)]
2+, where IL is an aromatic
intercalating ligand and AL is a bidentate ancillary ligand. The
nature of these complexes allows for the modulation of their
chemical properties via the use of different IL and AL combi-
nations.11 These PCs differ from cisplatin in that they will
reversibly intercalate between the base pairs of DNA rather
than covalently bind.12 Our most active compound to date,
[(5,6-dimethyl-1,10-phenanthroline)(1S,2S-diaminocyclohexane)
platinum(II)] dichloride is up to 100 times more active than cis-
platin in a variety of cell lines, with an IC50 of 0.009 ±
0.002 μM in the L1210 murine leukaemia cell line.13 Despite
the high activity of these complexes, there is much that is
unknown regarding their mechanism of action.13 A prominent
example is that no clear correlation has been found between
the DNA binding affinity and the cytotoxicity of these
complexes.11,14,15
In this study, we have attempted to find such a correlation
through both the synthesis of several platinum(II) anticancer
complexes and the study of their DNA binding via fluorescent
intercalator displacement assays (FIDs). The complexes syn-
thesised here incorporated either dipyrido[3,2-f:2′,3′-h]quin-
oxaline (dpq) or 2,3-dimethyl-dpq (23Me2dpq) as an IL and one
†Electronic supplementary information (ESI) available: Further synthesis and
characterisation data including detailed spectra. CCDC 1008700 for [Pt(dpq)(SS-
dach)](ClO4)2·1.75H2O. For ESI and crystallographic data in CIF or other elec-
tronic format see DOI: 10.1039/c4dt02133a
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of the R,R or S,S isomers of either 1,2-diaminocyclohexane (SS-
dach or RR-dach) or 1,2-diaminocyclopentane (SS-dacp or RR-
dacp) as an AL (Fig. 1). These compounds were synthesised in
order to determine the influence of the size of the IL on the
DNA binding affinity and cytotoxicity of these PCs. It was pos-
tulated that the use of the larger IL dpq would result in com-
plexes with higher DNA binding affinity, and subsequently
higher cytotoxicity, than the established complexes incorporat-
ing 1,10-phenanthroline derivatives. This is due to the larger
aromatic surface area of dpq, which could result in stronger
π-stacking interactions between the ligand and DNA base-pairs
during intercalation.16 Both dach and dacp were used as ALs as
each of these ligands are known to have a different yet positive
influence on the cytotoxicity of PCs.10
Here we present the synthesis of eight PCs, including [Pt-
(dpq)(SS-dach)]Cl2 (1), [Pt(dpq)(RR-dach)]Cl2 (2), [Pt-
(23Me2dpq)(SS-dach)]Cl2 (3), [Pt(23Me2dpq)(RR-dach)]Cl2 (4),
[Pt(dpq)(SS-dacp)]Cl2 (5), [Pt(dpq)(RR-dacp)]Cl2 (6), [Pt-
(23Me2dpq)(SS-dacp)]Cl2 (7), and [Pt(23Me2dpq)(RR-dacp)]Cl2
(8). The L1210 murine leukaemia cell line cytotoxicity and calf-
thymus DNA (CT-DNA) binding affinity of these complexes
were determined and compared to similar complexes incorpor-
ating the ILs 1,10-phenanthroline (phen) and 5,6-dimethyl-
1,10-phenanthroline (56Me2phen) (Fig. 1). These complexes
are [Pt(phen)(SS-dach)]Cl2 (9), [Pt(phen)(RR-dach)]Cl2 (10), [Pt-
(56Me2phen)(SS-dach)]Cl2 (11), [Pt(56Me2phen)(RR-dach)]Cl2
(12), [Pt(phen)(SS-dacp)]Cl2 (13), [Pt(phen)(RR-dacp)]Cl2 (14),
[Pt(56Me2phen)(SS-dacp)]Cl2 (15) and [Pt(56Me2phen)(RR-
dacp)]Cl2 (16).
Experimental
Materials
Reagents were used as received and all solvents were of analyti-
cal grade or higher. Dpq and 23Me2dpq were synthesised
using published methods.17,18 SS-dach, RR-dach, 1S,2S-di-
aminocyclopentane-dihydrochloric acid, 1R,2R-diaminocyclo-
pentane-dihydrochloric acid, dipotassium hydrogen
orthophosphate, potassium dihydrogen orthophosphate, pot-
assium perchlorate, sodium chloride, ethylenediamine tetra-
acetic acid (EDTA), calf-thymus DNA (CT-DNA) and ethidium
bromide were obtained from Sigma-Aldrich chemicals. Aceto-
nitrile and sodium hydroxide were obtained from Merck and
methanol was obtained from Lab Scan. Potassium tetrachloro-
platinate was obtained from Precious Metals Online. Lastly,
deuterated solvents D2O and DMSO-d6 were obtained from
Cambridge Isotope Laboratories.
Physical measurements
NMR spectra were obtained on a 400 MHz Bruker Avance
nuclear magnetic resonance spectrometer, either in D2O
(25 °C) or DMSO-d6 (35 °C), referenced internally to the
solvent. 1H spectra were obtained using a spectral width of
15 ppm and 256 accumulations. 1H-195Pt HMQC spectra were
obtained using a spectral width of 2500 ppm and 256 data
points for the 195Pt nucleus (F1 dimension), and a spectral
width of 12 ppm and 2048 data points for the 1H nucleus (F2
dimension). The following abbreviations apply to spin multi-
plicity: s (singlet), bs (broad singlet), d (doublet), dd (doublet
of doublets) t (triplet), and m (multiplet). The chemical shift
(parts per million) of each resonance were quoted as an
approximate midpoint of its multiplicity.
Mass spectra were obtained on a Waters Micromass ZQ
quadrupole mass spectrometer, using the positive electrospray
ionisation mode. Samples were prepared in a solution of water
and MeCN (1 : 1). Each sample was injected with a cone
voltage of 40 V, source temperature of 130 °C and desolvation
temperature of 350 °C. Spectra were collected over 1.5 minutes
with an m/z range of 100–1000.
Microelemental analysis (C, H and N) was performed at the
Chemical Analysis Facility, Department of Chemistry and
Biomolecular Sciences, Macquarie University. An Elemental
Analyser, Model PE2400 CHNS/O produced by PerkinElmer,
USA, was used.
Electronic spectra were recorded on a Cary 1E spectropho-
tometer at room temperature in the 200–400 nm range, using
Fig. 1 The general structure of the PCs investigated here, showing each compound number and their IL (blue) and AL (green, * indicates stereo-
centres). Also shown is the symmetrical proton numbering system adopted for NMR chemical shift assignment, and counter ions have been omitted
for clarity.
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a 10 mm quartz cell. All samples were automatically corrected
for solvent baseline.
Circular dichroism spectra were obtained using a Jasco-810
spectropolarimeter at room temperature. The instrument was
left to equilibrate for 30 minutes prior to use. Spectra were
obtained in a 10 mm quartz cell, and were measured from
400–195 nm with a data pitch of 1 nm, bandwidth of 1 nm
and response time of 1 second. For each spectrum, 40 accumu-
lations were collected and a water baseline was subtracted.
High performance liquid chromatography experiments were
performed on an Agilent Technologies 1260 Infinity machine,
using a Varian Polaris C18-A reverse phase column (4.6 ×
250 mm, 5 μm pore size). The mobile phase consisted of
formic acid (12.5 mM) in a methanol–water mixture (37 : 64).
Elution occurred isocratically with an injection volume of
2.5 μL and a flow rate of 0.8 μL min−1. Detection was achieved
through a photodiode array, with an absorbance wavelength
range of 190–600 nm. An integration threshold height rejec-
tion of 5 mAU was used to determine the percentage contri-
bution of each absorbance peak.
X-ray crystallography
Data collection was performed on an Agilent Technologies
SuperNova (Dual Source) System (Mo Kα, λ = 071073 Å)
equipped with an Oxford Cryosystems nitrogen gas cryostream
at 150(2) K. Data was processed using CrysAlisPro.19 The struc-
tures were solved by direct methods using SIR97,20 then
refined and extended with SHELXL-2013 within the
WinGX-32 graphical user interface.21,22 Anisotropic thermal
parameters were applied to all non-hydrogen atoms. Carbon-
bound hydrogen atoms were included in idealised positions
and refined using a riding model. Nitrogen bound hydrogen
atoms were first located in the difference Fourier map before
refinement, while water hydrogen atoms could not be located
and were not included in the model. Three of the perchlorate
anions are disordered, each modelled over two equal occu-
pancy positions. A number of bond length and angle restraints
were required to facilitate realistic modelling of the disorder.
Crystallographic data is summarised in Table 1.†
Fluorescent intercalator displacement assays
The binding of complexes 1–16 to CT-DNA was analysed
through monitoring of the fluorescence of a solution of ethi-
dium-bound CT-DNA in buffer (5 mM K2HPO4–KH2PO4,
50 mM NaCl, 1 mM EDTA). The stock CT-DNA (220 μM)
and ethidium bromide (441 μM) solution concentrations
were confirmed using the extinction coefficients of ε260 =
13200 M−1 cm−1 per base pair and ε476 = 5680 M
−1 cm−1,
respectively.23,24 These stock solutions were combined with
solutions of PC and buffer as per Table S4.1,† and the emis-
sion intensities at 601 nm were recorded. Emission was
measured using a Varian Cary Eclipse fluorescence spectro-
photometer. Samples were measured in a 96 well plate with a
sample volume of 250 μL. The excitation wavelength was
530 nm, and fluorescence intensity was measured from
550–750 nm with a 1 nm data interval, a scan rate of 600 nm
min−1 and an averaging time of 0.1 s. The excitation and emis-
sion slits were set to 5 nm and 10 nm, respectively, and all
experiments were performed at room temperature in duplicate.
In vitro growth inhibition assays
In vitro growth inhibition assays of the synthesised complexes
and cisplatin were performed at the Peter MacCallum institute
in Melbourne, Victoria, Australia. Each complex was dissolved
in water before being diluted with the appropriate cell media
to the required concentration. The experiments were per-
formed in the L1210 murine leukaemia cell line using the
Coulter Counting Assay. For each complex, two independent
experiments were performed, each with an exposure time of
48 h.
General synthesis of [Pt(IL)(AL)]Cl2
Synthesis was achieved using an adaptation of the published
method.25 K2PtCl4 (218 mg, 0.53 mmol) and AL (1 equiv.) were
combined and stirred in water (10 mL), and cooled at 4 °C for
24 h. The ligand dacp was obtained as a dihydrochloride salt,
and so in this case it was dissolved in water separately and the
pH of the solution increased to ∼10 using sodium hydroxide
before the addition of K2PtCl4. The resultant precipitate was
collected by vacuum filtration and washed (with water, ethanol
and diethyl ether, each 10 mL) to obtain the yellow product
[Pt(AL)Cl2] (Yield 89%). This product was refluxed (110 °C, 2 d)
with the IL (1.1 equiv.). The volume of the solution was
reduced under pressure by ∼50% before reflux for another 2 d.
The solution was cooled overnight to precipitate excess IL and
Table 1 The crystallographic parameters for [Pt(dpq)(SS-dach)]-
(ClO4)2·1.75H2O
Parameters Values
Empirical formula C20H22.5Cl2N6O9.75Pt
Formula weight 771.95
Temperature/K 150(2)
Crystal system Monoclinic
Space group P21(#4)
a/Å 8.4187(2)
b/Å 16.5210(4)
c/Å 18.4677(4)
α/° 90.0
β/° 100.027(2)
γ/° 90.0
Volume/Å3 2529.36(10)
Z 4
ρcalc/mg mm
−3 2.027
μ/mm−1 5.824
F(000) 1510
Crystal size/mm 0.2 × 0.1 × 0.1
Theta range for data collection 2.872 to 29.641°
Index ranges −10 ≤ h ≤ 10, −21 ≤ k ≤ 20,
−24 ≤ l ≤ 24
Reflections collected 29 166
Independent reflections 11 520 [R(int) = 0.0488]
Data/restraints/parameters 11 520/135/2692
Goodness-of-fit on F2 1.029
Final R indexes [I > 2σ(I)] R1 = 0.0504, wR2 = 0.1095
Final R indexes [all data] R1 = 0.0902, wR2 = 0.1316
Flack parameter 0.014(10)
Largest diff. peak/hole/e Å−3 3.028/−1.944
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filtered through a 0.45 μm filter using a syringe. The volume
was then reduced to ∼3 mL through rotary evaporation. To
purify, a Sep-Pak® (20 cc, 2 g) was activated through the
elution of methanol (15 mL) and water (30 mL). The [Pt(IL)-
(AL)]Cl2 solution was loaded onto the column and eluted with
water. The first 10 mL to elute was discarded and the remain-
ing yellow band was collected, leaving an orange band at the
head of the column. This solution was lyophilised to produce
a pale yellow solid. NMR data is reported in Table 2 while yield
and other characterisation data are presented in Table 3. Crys-
tals of the complex [Pt(dpq)(SS-dach)](ClO4)2·1.75H2O were
produced by the addition of KClO4 to a concentrated solution
of complex 1 in water, followed by the slow evaporation of the
solvent.
Results and discussion
Synthesis and characterisation
The synthesis of complexes 1–8 was achieved via adaptation of
published methods.25 Firstly, the water-soluble K2PtCl4 and AL
were reacted to form the water-insoluble product [Pt(AL)Cl2],
which was easily isolated via filtration. Secondly, this complex
was refluxed with the desired IL to produce [Pt(IL)(AL)]Cl2. This
reflux method is commonly used for complexes of this type;
however, dpq and 23Me2dpq are less water-soluble than phen
and so even with reflux periods spanning up to four days,
undissolved IL and [Pt(AL)Cl2] remained once the reaction solu-
tion was cooled. This resulted in yields that were typically
10–20% lower than previous syntheses.10 However, the higher
Table 2 Summary of the characterisation data of complexes 1–8
No. Molecular formula
Yield
(%)
ESI-MS (m/z)
Microanalysis Calc.
(Found)
UV/λmax (nm)
(ε/mol−1 dm3
cm−1) × 103
CD/λmax (nm)
(mdeg L mol−1) × 10−1
HPLC
peak
area
[M − H]+
Calc. (Found) C H N
1 [Pt(dpq)(SS-dach)]Cl2·
2H2O
86 540.2 (539.6) 37.04
(37.21)
4.04
(3.76)
12.96
(12.96)
257 (50), 348 (4) 204 (−24), 227 (15), 257 (−18),
300 (−11), 339 (5)
>99%
2 [Pt(dpq)(RR-dach)]Cl2·
2H2O
74 540.2 (539.4) 37.04
(37.23)
4.04
(3.72)
12.96
(12.97)
258 (50), 348 (4) 204 (20), 226 (−15), 256 (23),
300 (15), 339 (−5)
>99%
3 [Pt(23Me2dpq)(SS-dach)]-
Cl2·4H2O
61 568.2 (567.0) 37.08
(36.77)
4.81
(4.69)
11.79
(11.72)
226 (23),
261 (45), 356 (4)
202 (−22), 228 (13), 260 (−14),
271 (−1), 288 (−11), 335 (6)
>98%
4 [Pt(23Me2dpq)(RR-dach)]-
Cl2·4H2O
57 568.2 (567.5) 37.08
(37.27)
4.81
(4.76)
11.79
(11.81)
226 (24),
261 (46), 356 (4)
204 (22), 228 (−11), 259 (23),
267 (8), 285 (18), 335 (−6)
>98%
5 [Pt(dpq)(SS-dacp)]-
Cl2·3H2O
73 526.1 (525.0) 34.98
(34.55)
4.02
(3.81)
12.88
(12.80)
257 (46), 348 (4) 203 (−27), 228 (12), 259 (−8),
275 (3), 302 (−11), 341 (5)
>99%
6 [Pt(dpq)(RR-dacp)]-
Cl2·3H2O
76 526.1 (525.3) 34.98
(34.82)
4.02
(3.81)
12.88
(12.81)
257 (47), 348 (4) 204 (29), 230 (−14), 256 (15),
275 (2), 303 (13), 340 (−6)
>99%
7 [Pt(23Me2dpq)(SS-dacp)]-
Cl2·3.5H2O
57 554.1 (553.6) 36.58
(36.60)
4.53
(4.31)
12.19
(12.19)
226 (23),
261 (44), 356 (4)
200 (−26), 228 (12), 258 (−10),
271 (5), 296 (−8), 339 (7)
>99%
8 [Pt(23Me2dpq)(RR-dacp)]-
Cl2·3.5H2O
58 554.1 (553.2) 37.58
(36.65)
4.53
(4.32)
12.19
(12.23)
226 (24),
261 (46), 356 (4)
202 (24), 229 (−9), 259 (15),
270 (2), 295 (10), 335 (−7)
>99%
Table 3 Summary of NMR data of complexes 1–8, showing chemical shift (ppm), integration, multiplicity and coupling constants for the eight
complexes synthesised. Experiments were performed in D2O, and so amine resonances were not observed due to proton exchange
Complex no.
Label 1 2 3 4 5 6 7 8
H2 9.20 (2H, s) 9.20 (2H, s) — — 9.20 (2H, s) 9.20 (2H, s) — —
H4 9.75 (2H, d,
J = 8.44 Hz)
9.75 (2H, d,
J = 8.40 Hz)
9.59 (2H, d,
J = 8.50 Hz)
9.27 (2H, d,
J = 8.50 Hz)
9.74 (2H, d,
J = 8.38 Hz)
9.75 (2H, d,
J = 8.45 Hz)
9.35 (2H, d,
J = 8.35 Hz)
9.40 (2H, d,
J = 8.37 Hz)
H5 8.16 (2H, dd,
J = 8.26,
5.62 Hz)
8.17 (2H, dd,
J = 8.36,
5.52 Hz)
8.14 (2H, dd,
J = 7.86,
5.93 Hz)
8.13 (2H, dd,
J = 8.06,
5.56 Hz)
8.15 (2H, dd,
J = 8.42,
5.56 Hz)
8.15 (2H, dd,
J = 7.53,
6.02 Hz)
8.17 (2H, dd,
J = 7.94,
5.80 Hz)
8.16 (2H, dd,
J = 7.85,
5.87 Hz)
H6 9.03 (2H, d,
J = 5.46 Hz)
9.03 (2H, d,
J = 5.30 Hz)
8.97 (2H, d,
J = 5.67 Hz)
8.97 (2H, d,
J = 5.67 Hz)
8.91 (2H, d,
J = 5.50 Hz)
8.92 (2H, d,
J = 5.51 Hz)
8.85 (2H, d,
J = 5.12 Hz)
8.87 (2H, d,
J = 5.32 Hz)
H1′ 2.72 (2H, m) 2.72 (2H, m) 2.73 (2H, m) 2.75 (2H, m) 3.56 (2H, m) 3.56 (2H, m) 3.60 (2H, m) 3.60 (2H, m)
H2′eq 2.22 (2H, d,
J = 12.10 Hz)
2.22 (2H, d,
J = 12.48 Hz)
2.23 (2H, d,
J = 11.97 Hz)
2.24 (2H, d,
J = 12.59 Hz)
— — — —
H3′eq 1.65 (2H, m) 1.65 (2H, m) 1.66 (2H, m) 1.65 (2H, m) — — — —
H2′ax 1.47 (2H, m) 1.47 (2H, m) 1.49 (2H, m) 1.50 (2H, m) — — — —
H3′ax 1.23 (2H, m) 1.24 (2H, m) 1.24 (2H, m) 1.26 (2H, m) — — — —
H3′ — — — — 2.31 (2H, m) 2.31 (2H, m) 2.34 (2H, m) 2.34 (2H, m)
H2′ax/eq — — — — 1.95 (2H, m) 1.95 (2H, m) 1.98 (2H, m) 1.98 (2H, m)
H2′ax/eq — — — — 1.58 (2H, m) 1.58 (2H, m) 1.63 (2H, m) 1.62 (2H, m)
–CH3 — — 2.83 (6H, s) 2.83 (6H, s) — — 2.80 (6H, s) 2.81 (6H, s)
1H/195Pt 9.12/−2812.6 9.13/−2812.6 9.07/−2792.6 9.08/−2792.6 9.01/−2548.2 9.02/−2548.2 8.97/−2539.8 8.97/−2539.8
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aromaticity of complexes 1–8 did assist Sep-Pak® purification;
the final product was retained on the column for longer, allow-
ing an impurity to elute first. NMR experiments determined
that this impurity was unreacted [Pt(AL)Cl2], and so this frac-
tion was discarded (section S1.1†).
Each complex was characterised by a combination of NMR
(sections S2.3 and S2.4†), electrospray ionization mass spectro-
metry (ESI-MS, section S2.5†), high performance liquid chrom-
atography (HPLC, section S2.6†), microanalysis, circular
dichroism (CD) spectroscopy (section S2.2†) and ultraviolet
(UV) spectroscopy (section S2.1†). The NMR spectra produced
by each complex showed the expected resonances and little to
no traces of impurity. The ESI-MS spectra confirmed the pres-
ence of the predicted parent ion (Table 2). The purity of each
complex was determined to be over 98% as per analysis of the
HPLC peak area and this was confirmed by the closeness of
the microanalysis data to the calculated values (Table 2). The
retention of chirality of the complexes during synthesis was
confirmed by CD spectra.
NMR spectral assignment
NMR characterisation of each PC was achieved using a combi-
nation of 1H NMR and 1H-195Pt heteronuclear multiple
quantum correlation (HMQC) spectra (Table 3). As an example,
the labelled 1H NMR spectrum of complex 1 is shown (Fig. 2).
Regarding the aromatic region, complex 1 produced a singlet
at 9.20 ppm; this was assigned H2 as there is no proton bound
to the adjacent carbon. The resonance at 8.16 ppm was
assigned H5 as the coupling of these protons to both H4 and
H6 would produce the observed doublet of doublets splitting
pattern.
To distinguish between the remaining aromatic doublets,
their coupling constants were compared; in pyridyl ring
systems, the proton located on the carbon in the alpha posi-
tion relative to nitrogen produces a smaller coupling constant
than protons in the H4 position.26 Therefore, the doublet at
9.03 ppm with J = 5.46 Hz was assigned H6 and the doublet at
9.75 ppm with J = 8.44 Hz was assigned H4. The resonances in
the aliphatic region were in agreement with previously pub-
lished complexes with the same range of ALs, and so peak
assignment was identical to the literature.10,27 The amine
proton resonances were not present in this spectrum due to
exchange with D2O. In the proton-platinum HMQC spectrum
of complex 1 (Fig. 3), the 195Pt chemical shift of −2812.6 ppm
is very different from those of [Pt(SS-dach)Cl2] and K2PtCl4
(−3282 ppm and −1650 ppm, respectively).10 This is indicative
of the presence of a single platinum complex that differs
greatly from the starting reagents. Secondly, the correlation
between the aromatic resonance at 9.58 ppm and the platinum
centre suggests that the IL has coordinated. Finally, there are
correlations between the platinum centre and the proton reso-
nances at 7.90 ppm and 7.07 ppm. These peaks were not
present in the D2O
1H NMR spectrum, and so they resulted
from the amines of the SS-dach AL. These correlations there-
fore confirm the coordination of each ligand to the platinum
centre.
The above methodology was used to assign the NMR
spectra of each of complexes 2–8 (S2.3†). However, some
minor differences in the NMR spectra of these complexes were
observed. In the 1H NMR spectrum of complexes incorporating
23Me2dpq, the resonance at 9.20 ppm was replaced by a
singlet at ∼2.82 ppm; this peak was assigned as the methyl
protons due to the relative integral of six and the singlet multi-
plicity. The 195Pt chemical shifts of complexes 5–8 were found
to be approximately 250 ppm higher than those of complexes
1–4. 195Pt is known to be extremely sensitive to small changes
in chemical structure,28 and so this difference in chemical
shift is possibly due to the high ring strain of the dacp AL rela-
tive to dach.29
UV spectra
The UV absorption spectrum of each of the complexes was
similar, and the choice of AL had little effect. Each spectrum
was dominated by a strong absorption band at ∼260 nm, with
a series of shoulders extending down to a weak band at
∼350 nm (Fig. 4). These bands are attributed to ligand-centred
π–π* transitions of the dpq and 23Me2dpq ligands; the weak
n–π* transitions are likely to be suppressed in a hydrogen-
bonding solvent. These bands are consistent with our own
semiempirical CNDO/S-CI calculations for dpq, using the
program of Del Bene et al.,30 with the updated code of
Fig. 2 The 1H NMR spectrum of complex 1 in D2O, showing proton
assignment.
Fig. 3 The 1H–195Pt HMQC spectrum of complex 1 in DMSO-d6, dis-
playing the correlations between the platinum centre and the protons
from each ligand.
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Reimers, with input geometries from B3LYP/6-31+G** calcu-
lations using Gaussian 03.31 The CNDO/S-CI program is para-
meterized for compounds of this general class, and performs
satisfactorily with low computational cost.
As shown in Fig. 4, the free ligand has a strong absorption
centred about 250 nm, weaker absorption around 290 nm, and
weak bands beginning at about 340 nm. A comparison
between the spectra of the complexes and the free ligand
shows a marked red-shift and loss of structure upon complexa-
tion. This behaviour parallels that for 1,10-phenanthroline
when complexed by platinum(II),32 and the redshift resembles
that for protonated ligands such as 2,2′-dipyridine33 and 1,10-
phenanthroline.34 We have attempted to reproduce this behav-
iour for dpq, but have been unable to produce sufficient con-
centrations of the protonated ligand in water. The complexes
incorporating 23Me2dpq exhibited a distinct peak at 226 nm,
rather than a shoulder; this feature has not been observed
in the UV spectra of complexes incorporating phen and
56Me2phen.
10
X-Ray crystal structure of [Pt(dpq)(SS-dach)](ClO4)2·1.75H2O
The perchlorate salt of the complex [Pt(dpq)(SS-dach)]2+ crys-
tallises in the monoclinic chiral space group P21 with two
molecules in the asymmetric unit. It features a square planar
metal centre and an N4-coordination sphere (Fig. 5). The rele-
vant bond lengths and angles, as well as the N–C–C–N torsion
angles in the complex, are shown in Table 4. The average
N–Pt–N bond angles of both dpq and SS-dach ligands while co-
ordinated to the platinum centre were 81.2° and 83.0°,
respectively. The average Pt–N bond lengths from the dpq and
SS-dach ligands to the platinum centre were determined to be
2.025 and 2.043 Å, respectively. These results are consistent
with those found in crystal structures of similar complexes.35,36
The N–C–C–N torsion angles (Table 4) for the complex, which
were observed as 2(2)° and 5(2)°, revealed a slight distortion
upon coordination in the planarity of the dpq ligands.
Upon coordination to the platinum centre, the SS-dach
ancillary ligand assumed the stable chair conformation, result-
ing in a puckered six-membered chelate ring in the δ-confor-
mation.37 This was evident by the positive values of the
average N–C–C–N torsion angles (Table 4) which was 54.3°.
These angles confirm the stereochemistry of the AL as S,S.
Additionally, the Flack parameter of 0.014(10) confirms the
absolute structure of the complex and the stereochemistry of
the ligands.38 Adjacent dpq ligands stack parallel to the crystal-
lographic b-axis with carbon-carbon distances in the range of
3.4–3.5 Å, indicating the presence of π-interactions (Fig. 5).39
The amine groups form a number of hydrogen bonds with
both the perchlorate anions and the solvent water molecules.
Intuitively, the number of associated water molecules deter-
mined by the elemental microanalysis correlates with the
number determined by this crystal structure.
Fluorescent intercalator displacement (FID) assays
Changes in the emission of fluorescent species during binding
events is an efficient way to determine the apparent binding
constant, Kapp, for the interactions of compounds with
Fig. 5 The X-ray structure of [Pt(dpq)(SS-dach)](ClO4)2·1.75H2O,
showing the atom numbering system (A) and top (B) and side (C)
packing views. The metal centres are shown in cerulean, the nitrogen
atoms in blue, the carbon in grey and hydrogen atoms in white; per-
chlorate anions and water molecules have been omitted for clarity.
Table 4 Selected bond distances and angles for the complex [Pt(dpq)-
(SS-dach)](ClO4)2·1.75H2O, as determined by X-ray crystallography.
Standard deviations are shown in parentheses
Bond distances (Å)
Pt1–N1 2.027(15) Pt2–N4 2.003(15)
Pt1–N5 2.066(13) Pt2–N11 2.035(11)
Pt1–N9 2.021(13) Pt2–N13 2.042(16)
Pt1–N28 2.049(16) Pt2–N16 2.025(11)
Bond angles and torsion angles (°)
N9–Pt1–N1 97.8(5) N16–Pt2–N11 178.0(5)
N9–Pt1–N28 80.9(6) N16–Pt2–N13 176.8(5)
N1–Pt1–N28 177.9(6) N1–Pt2–N5 96.7(5)
N9–Pt1–N5 173.3(5) N11–Pt2–N13 82.7(5)
N1–Pt1–N5 83.2(6) N1–C20–C15–N5 56.0(18)
N28–Pt1–N5 98.3(6) N4–C28–C29–N16 2(2)
N4–Pt2–N16 81.5(5) N28–C7–C8–N9 5(2)
N4–Pt2–N11 99.0(5) N11–C35–C40–N13 52.5(16)
Fig. 4 UV absorption spectra of complex 1 (water) and free dpq
(ethanol).
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biomolecules such as proteins and DNA.40–42 As such, fluo-
rescence spectroscopy was utilised in this study to investigate
the interactions of complexes 1–16 with CT-DNA. Fluorescent
intercalator displacement assays (FIDs) were used as neither
the PCs or CT-DNA are intrinsically fluorescent. In these
assays, CT-DNA solutions are bound with ethidium bromide
(EtBr), a compound known to exhibit fluorescence only when
bound with DNA.43 The addition of a competitively binding PC
results in the displacement of bound EtBr and a subsequent
loss in emission of the solution. Therefore, changes in emis-
sion upon the incremental addition of these competitive
binders can be used to calculate Kapp. EtBr is postulated to
occupy more than one binding site of DNA with an overall Kapp
of ∼105 M.44,45 Therefore, the PC Kapp values calculated from
FIDs are an average of the PC-DNA affinity across each of the
sites from which EtBr is displaced.
For the FID assays in this study, a series of solutions were
measured in which the CT-DNA and EtBr concentrations were
kept constant while the amount of complexes 1–16 was incre-
mentally increased (Table S3.1†). The addition of each PC to
EtBr-bound CT-DNA resulted in a quenching of the fluo-
rescence signal, indicating that each of the complexes dis-
placed EtBr from the base-pair binding sites. Intuitively, the
attenuation of emission was larger for higher PC concen-
trations. This can clearly been seen in Fig. 6 in which the
addition of complex 1 to EtBr-bound DNA has resulted in
the attenuation of the peak at 601 nm. All of the complexes in
the study produced similar emission spectra (section S3.2†).
Prior to the calculation of binding constants from this data,
the nature of the fluorophore and quencher interactions had
to be determined. Quenching of fluorescence can occur via
several processes, including energy transfer, excited-state reac-
tions, collisional quenching and static quenching.46
Collisional quenching occurs when the fluorophore and
quencher interact during the excitation of the fluorophore,
whereas static quenching occurs during the formation of a
fluorophore-quencher complex in the ground state.46 The
Stern–Volmer equation describes the relationship between the
fluorescence of a fluorophore (ethidium-bound CT-DNA) and
concentration of quencher (the PC) in solution:47
F0
F
¼ 1þ Kqτ0 PC½  ¼ 1þ KSV½PC ð1Þ
where F0 is the fluorescence of the binding site in the absence
of quencher, F is the fluorescence of the site containing the
PC, Kq is the bimolecular quenching constant, τ0 is the lifetime
of the chromophore in the absence of the quencher (23 × 10−9
s for ethidium-bound DNA),48 and KSV is the Stern–Volmer
quenching constant. KSV can be determined from the slope of
a plot of F−1/F0 against [PC], and Kq can subsequently be deter-
mined from KSV and τ0. If the calculated Kq is ∼2 × 1010 M−1
s−1, the fluorescence has been quenched through collisional
means, whereas a Kq above the same value indicates that static
quenching has occurred.49 Using Stern–Volmer plots, Kq was
calculated for each complex (Table S3.3†). Each value was
above 2 × 1010 M−1 s−1, indicating that the quenching of EtBr
by each PC occurs statically rather than dynamically; that is,
quenching occurs when the PC-DNA complex forms through
displacement of EtBr. Due to the static nature of quenching,
the displacement of ethidium by each PC can be represented
by:
nPCþ BE ! nBM þ EtBr ð2Þ
where n is the number of DNA binding sites from which a PC
has displaced EtBr, and BE and nBM represent DNA that is
bound by EtBr and n molecules of PC, respectively. During the
calculation of Kapp, it is typically assumed that each EtBr mole-
cule is permanently displaced from the DNA binding site,
therefore having no effect on the Kapp of the quencher.
50–52
The Kapp for this interaction can therefore be written as:
Kapp ¼ nBM½ PC½ n½BE ð3Þ
During the displacement process, the initial concentration
of EtBr-bound binding sites, BE0, is equal to the total concen-
tration of the PC-bound and EtBr-bound sites through eqn (4):
½BE0  ¼ ½BE þ ½nBM ð4Þ
The ratio between concentration and fluorescence (F) of BE
and BE0 is represented by:
BE½ 
BE0½ 
¼ F½ 
F0½  ð5Þ
Manipulation of these expressions reveals the logarithmic
relationship, eqn (6):
log 10
F0  F
F
 
¼ n log 10½PC þ log 10 Kapp ð6Þ
Therefore, the double-logarithm plot of log10(F0 − F/F)
against log10[PC] can be used to determine Kapp and n from
the intercept and slope, respectively. The plots generated for
each complex (section S3.2†) were linear over the entire
Fig. 6 Emission spectra of CT-DNA (73.5 μM) and EtBr (29.4 μM) with
increasing concentration of complex 1. [K2HPO4–KH2PO4] = 5 mM,
[NaCl] = 50 mM, [EDTA] = 1 mM.
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concentration range tested; a summary of the data determined
for each PC is shown in Table 5.
It can be seen that each of the MCs tested displayed a high
affinity for CT-DNA, with a range of Kapp values from 10
3–107
M−1. For complexes 9–16, the use of 56Me2phen as an IL
resulted in a much higher DNA binding affinity than the use
of phen. Interestingly, Kapp values for complexes 1–8 were all
similar, suggesting that the methyl substituents did not
impact DNA binding affinity (Fig. 7).
A generally positive correlation between Kapp and n was
observed, which intuitively indicates that the complexes with
higher DNA binding affinity were able to displace a higher
number of EtBr molecules. The complexes incorporating dpq
(1, 2, 5, 6) demonstrated much higher binding affinities than
those incorporating phen (9, 10, 13, 14). This is thought to be
due to the larger aromatic surface of the dpq IL, as it contains
a higher density of π-electrons that can stack with the base-
pairs in the binding site. However, the same trend was not
observed in complexes that incorporated the methylated inter-
calating ligands; the 56Me2phen complexes (11, 12, 15, 16)
bound to CT-DNA with greater affinity than those incorporat-
ing both dpq and 23Me2dpq (1–8). This suggests that the struc-
ture of the 56Me2phen IL is the optimum size when it comes to
DNA binding affinity.
Contrary to what has been determined here, a previous
study of the DNA binding affinity of a range of complexes with
varied surface areas has determined that some dpq complexes
do not bind to CT-DNA with a higher affinity than phen com-
plexes.11 However, this study utilised circular dichroism (CD)
spectroscopy to analyse PC-DNA binding rather than FIDs. It is
clear that different spectroscopic techniques and assay con-
ditions may produce different results;53–55 further investigation
into these differences and DNA binding trends is warranted.
In vitro cytotoxicity
The biological activity of complexes 1–8 were determined in
the L1210 murine leukaemia cell line in order to compare
them to previously studied complexes of this type. Despite the
similarities in chemical structure, complexes 1–8 produced a
wide variety of IC50 values (Table 6, Fig. 8). As per the pre-
Fig. 7 Comparison of the CT-DNA binding affinity of complexes 1–16,
represented by the calculated Kapp with standard error.
Table 5 Summary of the binding data obtained from the double-logarithm plots of the PCs tested. Standard errors (±) are quoted to two decimal
places
No. n Kapp/M
−1 No. n Kapp/M
−1
1 1.12 ± 0.03 (1.9 ± 0.1) × 105 9 0.79 ± 0.01 (1.88 ± 0.01) × 103
2 1.16 ± 0.01 (3.5 ± 0.7) × 105 10 0.8 ± 0.1 (4.0 ± 0.1) × 103
3 1.14 ± 0.02 (2.9 ± 0.5) × 105 11 1.35 ± 0.01 (2.1 ± 0.3) × 106
4 1.17 ± 0.09 (3.9 ± 0.4) × 105 12 1.35 ± 0.01 (2.4 ± 0.5) × 106
5 1.07 ± 0.01 (1.18 ± 0.01) × 105 13 0.87 ± 0.02 (4.8 ± 0.2) × 103
6 1.10 ± 0.01 (1.40 ± 0.09) × 105 14 0.8 ± 0.1 (3.0 ± 0.7) × 103
7 1.17 ± 0.01 (3.7 ± 0.1) × 105 15 1.30 ± 0.01 (1.15 ± 0.09) × 106
8 1.19 ± 0.02 (3.47 ± 0.07) × 105 16 1.45 ± 0.04 (1.7 ± 0.1) × 106
Table 6 In vitro cytotoxicity of complexes 1–16 in the L1210 murine leukaemia cell line, expressed as IC50 values with standard error. PC activity
was also compared to cisplatin
Complex
no. IL AL IC50/μM
IC50
(SS–RR)
Comparison
complex no. IL AL IC50/μMa
IC50
(SS–RR)
1 dpq SS-dach 0.19 ± 0.01 −0.61 9 Phen SS-dach 0.10 ± 0.01 −1.40
2 dpq RR-dach 0.80 ± 0.20 10b Phen RR-dach 1.50 ± 0.10
3 23Me2dpq SS-dach 1.30 ± 0.40 −4.70 11 56Me2phen SS-dach 0.009 ± 0.002 −0.451
4 23Me2dpq RR-dach 6.00 ± 2.00 12 56Me2phen RR-dach 0.46 ± 0.01
5 dpq SS-dacp 4.10 ± 0.90 1.85 13 Phen SS-dacp 2.80 ± 0.30 1.20
6 dpq RR-dacp 2.25 ± 0.07 14 Phen RR-dacp 1.60 ± 0.01
7 23Me2dpq SS-dacp 4.20 ± 0.80 −0.80 15 56Me2phen SS-dacp 0.23 ± 0.03 0.06
8 23Me2dpq RR-dacp 5.00 ± 1.00 16 56Me2phen RR-dacp 0.17 ± 0.04
Cisplatin — — 0.43 ± 0.06 —
a Taken from ref. 10 and those within. b Tested as a perchlorate, rather than a chloride salt.
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viously reported trends,10 the complexes incorporating dach
produced lower IC50 values than those incorporating dacp.
Complexes 1–6 followed the same trend as the previously-
reported complexes 11–18; the S,S isomers of the dach-incor-
porating complexes were more active than the R,R, while the
opposite was true for the complexes incorporating dacp. This
confirms that the AL had more of an influence on the activity
of these complexes than the IL. The exceptions to these trends
were complexes 7 and 8, as they were approximately equal in
cytotoxicity.
In general, each dpq derivative-incorporating complex was
less cytotoxic than the phen derivate counterpart. Interestingly,
the complexes incorporating dpq were much less active than
those containing phen, despite the higher DNA binding
affinity determined using FIDs. These results suggest that the
DNA binding of these complexes is not the only intracellular
interaction that contributes to their cytotoxicity, and supports
the notion that the activity of these complexes arises from con-
tributions of both the IL and AL. An unexpected trend amongst
the complexes tested was that the use of methylated ILs
resulted in much higher cytotoxicity for 9–16, whereas the
opposite effect was observed for 1–8. It is clear that the pres-
ence of methyl substituents on the IL of PCs will not always
result in higher levels of biological activity.
Conclusion
Eight platinum complexes of the type [Pt(IL)(AL)]Cl2, six of
which are novel, were synthesised using an adaptation of pub-
lished methods. The purity of each complex was determined
via a variety of spectroscopic techniques. The CT-DNA binding
affinities of these complexes were compared to those of the
published complexes 9–16 through the use of fluorescent
intercalator displacement assays. The order of binding affinity
in relation to the IL used was 56Me2phen > 23Me2dpq = dpq >
phen. These results indicate that an increased aromatic
surface area and methylation of the IL may independently
result in a higher DNA binding affinity; however a combination
of these two characteristics is not guaranteed to produce
higher efficacy. Due to different trends observed between this
study and another,11 further investigation is required in order
to elucidate the true nature of PC-DNA binding in relation to
the choice of IL. Finally, each of complexes 1–8 were found to
be cytotoxic to the L1210 cell line, with complex 1 being more
active than cisplatin. Overall, the dpq-containing complexes
were not as active as complexes 9–16, although further testing
in other cell lines may reveal different trends.
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